Pharmacokinetic Properties of Lorcaserin in Subjects With Renal Impairment
NCT00828438
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
40
Enrollment
INDUSTRY
Sponsor class
Conditions
Renal Impairment
Interventions
DRUG:
Lorcaserin 10mg
Sponsor
Eisai Inc.